Primary aim of the study was to enhance the understanding of SSTR2 expression in SCLC in correlation with histopathology, standard of care molecular imaging, and patient outcomes, ultimately contributing to improved personalized management strategies for SCLC patients. The gene discussed is SSTR2; the disease is small cell lung carcinoma.